Best for: menopause-stage readers who want GLP-1 and HRT in one place
Patients interested in access should speak with their GP or obesity medicine specialist about eligibility for ongoing MHRA-authorised clinical trials
doi:10.3390/jcm12010145 3.Perkovic V, Tuttle KR, Rossing P, et al
4.7 out of 5 from our editorial team, backed by an industry-leading 4.7-star Trustpilot rating from 15,750+ reviews, 8-biomarker lab testing, dietitian and meal plan support, and a unique 10% weight loss guarantee with money-back promise
Independent Wellness provides clinician-prescribed options, lab monitoring, and prescription delivery to eligible patients who want supervised GLP-1 care
Several mechanisms are thought to contribute, and these should be understood as hypotheses based on the drug's pharmacology and observations from related incretin-based therapies: Reduced caloric intake: Retatrutide significantly suppresses appetite, often leading to a substantial reduction in food consumption